Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study

about

Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study

Item

http://www.wikidata.org/entity/Q37205614

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Off-label use of rilpivirine i ...... patients: A multicenter study

@en

Off-label use of rilpivirine i ...... patients: A multicenter study.

@nl

type

Item

label

Off-label use of rilpivirine i ...... patients: A multicenter study

@en

Off-label use of rilpivirine i ...... patients: A multicenter study.

@nl

prefLabel

Off-label use of rilpivirine i ...... patients: A multicenter study

@en

Off-label use of rilpivirine i ...... patients: A multicenter study.

@nl

P1476

Off-label use of rilpivirine i ...... patients: A multicenter study

@en

P2093

Clàudia Fortuny

http://www.w3.org/2001/XMLSchema#string

Elena Bermúdez Moreno

http://www.w3.org/2001/XMLSchema#string

Juan Luis Santos

http://www.w3.org/2001/XMLSchema#string

Lola Falcon-Neyra

http://www.w3.org/2001/XMLSchema#string

Marie Antoinette Frick

http://www.w3.org/2001/XMLSchema#string

María Isabel González-Tomé

http://www.w3.org/2001/XMLSchema#string

María Luisa Navarro Gómez

http://www.w3.org/2001/XMLSchema#string

Olaf Neth

http://www.w3.org/2001/XMLSchema#string

Peter Olbrich

http://www.w3.org/2001/XMLSchema#string

Santiago J De Ory

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetics, pharmacogenomics, and individualized medicine

A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe).

Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.

A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth.

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects

Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.

Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.

Update of the drug resistance mutations in HIV-1: March 2013.

P304

e3842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000003842

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pere Soler-Palacín

Claudia Palladino

Antoni Noguera-Julian

Verónica Briz

Luis Fernando López-Cortés

Grupo de Estudio de la Infección Fúngica Invasiva de la Sociedad Española de Infectología Pediátrica (SEIP)

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27310962

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4998448

http://www.w3.org/2001/XMLSchema#string